Half of the patients who received an experimental vaccine for pancreas cancer being developed by Roche and BioNTech following ...

Pancreatic cancer is one of the deadliest types of cancer, with fewer than 13% of people diagnosed with it surviving for more ...

A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study ...

The five-year survival rate of people diagnosed with pancreatic cancer is currently 13 percent. Two breakthroughs are ...

The new medication is personalized for each patient's tumor, mobilizing the immune system to attack cancer cells with few ...

A team of Yale researchers recently published promising results from a clinical trial testing the effectiveness of a new ...

Results from a trial of an mRNA vaccine for pancreatic cancer have shown that the vaccine reduces the chance of the cancer ...

For decades, researchers have worked to create drugs that teach the immune system to kill cancer cells the way traditional ...

Robert F. Kennedy Jr. highlighted the rapid spread of measles in Texas, particularly among unvaccinated children. He urged ...

Immune cell populations of people with post-vaccination syndrome had lower levels of effector CD4 T cells and higher levels ...

Although the findings are promising, these vaccines are still in the early stages of testing." The team is planning a larger ...